Federal Register of Legislation - Australian Government

Primary content

PB 75 of 2022 Other as made
This instrument amends the National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021).
Administered by: Health and Aged Care
Registered 29 Jul 2022
Tabling HistoryDate
Tabled HR01-Aug-2022
Tabled Senate02-Aug-2022
To be repealed 23 Nov 2022
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 75 of 2022

 

National Health (Listed Drugs on F1 or F2) Amendment Determination 2022 (No. 6)

I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following determination.

Dated               28 July 2022               

NIKOLAI TSYGANOV

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

 

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021)                2

 

 


1  Name

                   This instrument is the National Health (Listed Drugs on F1 or F2) Amendment Determination 2022 (No. 6).

                   This instrument may also be cited as PB 75 of 2022.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 August 2022.

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 85AB(1) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021)

1  Schedule 1, after item dealing with Diphtheria and tetanus vaccine, adsorbed, diluted for adult use   

insert:

Diroximel fumarate

2  Schedule 1, after item dealing with Fosaprepitant   

omit:

Fotemustine

3  Schedule 1, after item dealing with Sirolimus

omit:

Sitagliptin

4  Schedule 2, after item dealing with Simvastatin

insert:

Sitagliptin

                        Sitagliptin with metformin